Aptose Biosciences Inc. - COM (APTO)

Q4 2023 13F Portfolio Holders as of 12/31/2023

Type / Class
Equity / COM
Number of holders
26
Total Shares
1.12M
Shares change
+33.7K
Total reported value, excl. options
$2.84M
Value change
+$82.8K
Put/Call ratio
0
Number of buys
11
Number of sells
-7
Price
$2.54
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.